★ the heart of the site · evidence-graded
A living, evidence-graded database of things people do — eat, take, and practice — that plausibly affect mitochondrial health. Inspired by the Alzheimer's Drug Discovery Foundation's Cognitive Vitality ratings, rebuilt from scratch for mitochondria and stretched well beyond pills into the lifestyle levers that move your cellular power plants.
87 interventions · 15 categories · rated for evidence, benefit & safety
Each entry gets three dials. EVIDENCE = quality of the human data (Strong = multiple RCTs / meta-analyses; Moderate = some RCTs or consistent cohorts; Preliminary = small or early human trials; Weak = little direct human data; Mixed = conflicting). BENEFIT = likely upside for mitochondrial function specifically. SAFETY = how safe for most healthy adults. Honest caveat: human trials rarely measure mitochondria directly, so many ratings lean on the best proxies — muscle-biopsy studies, VO2max, metabolic and oxidative-stress markers — plus mechanism. This is a synthesis for orientation, not medical advice. Talk to a clinician before changing anything.
The single best-validated mitochondrial intervention. Muscle-biopsy RCTs and meta-analyses show endurance training raises mitochondrial content, enzyme activity and VO2max at every age.
Time-efficient and potent: trials show HIIT boosts mitochondrial content and respiration, with especially large VO2max gains. Slightly more caution for people with cardiac risk.
Beyond building muscle, resistance training improves mitochondrial quality and function, particularly in older adults where it partly reverses age-related decline.
Breaking up prolonged sitting improves glucose handling and metabolic health; prolonged inactivity down-regulates mitochondrial genes in muscle.
The most robustly evidenced dietary pattern for cardiometabolic and brain health (incl. PREDIMED RCT). Rich in polyphenols and omega-3s that support mitochondrial function and lower oxidative stress.
RCTs show dietary nitrate improves mitochondrial efficiency (more ATP per oxygen) and exercise economy — one of the few foods with a direct human mitochondrial readout.
Flavanols improve vascular and metabolic markers (COSMOS trial for CV events); mechanistic and small human data suggest stimulation of mitochondrial biogenesis via nitric oxide.
Large cohorts link moderate coffee to lower all-cause mortality; caffeine activates AMPK and promotes autophagy/mitophagy in mechanistic studies.
Catechins activate AMPK and may support biogenesis; human data are mostly on metabolic markers and are modest.
Anthocyanin-rich berries improve vascular and cognitive markers in small RCTs; mitochondrial effects are inferred from antioxidant and Nrf2 pathways.
A core Mediterranean component; polyphenols like oleocanthal have anti-inflammatory and mitochondrial-protective actions, with strong cardiometabolic human evidence.
EPA/DHA incorporate into mitochondrial membranes; RCTs show improved muscle mitochondrial function and metabolic markers, though outcomes vary by population.
Gut bacteria convert ellagitannins to urolithin A, a mitophagy inducer with growing human trial support (see Urolithin A supplement).
A potent Nrf2 activator that boosts endogenous antioxidant defenses; human trials are small but mechanistically compelling for mitochondrial protection.
Wheat germ, natto and aged cheese are spermidine sources; cohorts link higher intake to lower mortality, and small trials show autophagy induction.
Chronic and heavy alcohol damages mitochondria in liver, muscle and brain, raising oxidative stress and impairing OXPHOS. No dose is clearly mitochondrially protective.
Diets high in ultra-processed food and sugar drive insulin resistance and lipotoxic mitochondrial dysfunction; strong cohort evidence links them to metabolic disease.
One of the best-evidenced supplements: buffers cellular ATP via the phosphocreatine system, improving performance and possibly brain energetics. Excellent safety record.
A direct electron-transport-chain carrier and antioxidant. RCTs support benefit in heart failure (Q-SYMBIO), statin myopathy and primary mitochondrial disease; general-population benefit is smaller.
The rare mitophagy inducer with real human RCTs: improves muscle mitochondrial gene expression and endurance in middle-aged and older adults.
Shuttles fatty acids into mitochondria for oxidation; RCTs show benefit in fatigue, some cardiovascular settings and carnitine-deficiency states.
A mitochondrial enzyme cofactor and antioxidant; best human evidence is for diabetic neuropathy, with plausible broader mitochondrial support.
Restores glutathione and, in small RCTs in older adults, improved mitochondrial function, insulin resistance and multiple aging markers. Promising but early.
Reliably raises blood NAD+ in humans; functional benefits (muscle, metabolic) are so far mixed and modest in RCTs. Well tolerated.
Another NAD+ precursor with early human trials suggesting improved muscle insulin sensitivity and physical measures; evidence is still thin and regulatory status is in flux.
Small human trials suggest PQQ influences mitochondrial biogenesis markers and fatigue; evidence is limited and short-term.
Cofactors for the respiratory chain; riboflavin helps specific riboflavin-responsive mitochondrial disorders, and niacin raised NAD+ and muscle strength in a small mitochondrial-myopathy trial.
ATP is biologically active as Mg-ATP; deficiency impairs energy metabolism, and correcting low magnesium improves metabolic and muscular function.
Correcting deficiency improved muscle mitochondrial oxidative function in human studies; benefit in already-replete people is unclear.
Concentrates in mitochondria as a potent antioxidant and supports circadian alignment; human mitochondrial-outcome data are early but mechanistically strong.
A CoQ derivative engineered to accumulate inside mitochondria; small human trials show vascular improvements, but broad clinical benefit is unproven.
A famous SIRT1/PGC-1α activator on paper, but human trials are inconsistent and often null; may even blunt some exercise adaptations. Underwhelming so far.
Anti-inflammatory and Nrf2-activating; human evidence is limited by poor bioavailability, though formulated versions show modest metabolic effects.
Essential for mitochondrial tRNA function; a 2023 aging paper generated buzz, but strong human longevity or mitochondrial-outcome RCTs are still lacking.
Mildly inhibits Complex I and activates AMPK — a hormetic stress that improves metabolic health; the TAME trial is testing aging endpoints. Note it can blunt some exercise gains.
Prescription diabetes/heart-failure drugs that shift fuel use toward ketones and appear to improve mitochondrial and cardiac energetics; mitochondrial-specific human data are emerging.
By improving weight and glycemic control, GLP-1 drugs relieve metabolic stress on mitochondria; direct mitochondrial human evidence is indirect and early.
Inhibits mTOR to boost autophagy and mitochondrial quality control — powerful in animal lifespan studies, but human anti-aging evidence is preliminary and it carries real immune/metabolic risks.
Cardioprotective overall, but they lower CoQ10 and can impair muscle mitochondrial function in susceptible people (statin-associated myopathy). A genuine double-edged case for mitochondria.
A plant alkaloid (sold OTC) that activates AMPK much like metformin, with meta-analyses supporting glycemic and lipid benefits; direct mitochondrial human data are limited.
Confining eating to a window improves metabolic markers in RCTs; the mitophagy/biogenesis mechanisms are strong in animals and emerging in humans.
Alternate-day and 5:2 fasting produce weight loss and metabolic benefits comparable to calorie restriction; mitochondrial adaptations are inferred from metabolic switching.
The CALERIE RCT showed sustained moderate calorie restriction increased muscle mitochondrial biogenesis markers and reduced oxidative damage in healthy adults.
Periodic low-calorie 'fasting-mimicking' cycles improved metabolic and aging biomarkers in human trials; longer-term and mitochondrial-specific data are still building.
Well-established for epilepsy (a mitochondrially-mediated effect) and promising for metabolic conditions; ketones may boost mitochondrial biogenesis, but adherence, lipids and long-term safety warrant caution.
Ketone esters and medium-chain triglycerides raise blood ketones as an efficient mitochondrial fuel; human functional benefits are early and context-dependent.
Sleep is when much mitochondrial and metabolic housekeeping happens; observational and experimental data tie short sleep to impaired mitochondrial and metabolic function.
Obstructive sleep apnea causes intermittent hypoxia that damages mitochondria and raises oxidative stress; CPAP reverses much of the metabolic and oxidative burden.
Curtailed or fragmented sleep raises oxidative stress and impairs insulin sensitivity and mitochondrial function — a common, modifiable mitochondrial stressor.
Mindfulness-based programs lower stress and inflammatory markers in RCTs; mitochondrial links run through reduced 'mitochondrial allostatic load' from chronic stress.
Sustained stress and glucocorticoids alter mitochondrial structure and function ('mitochondrial allostatic load'), a well-argued pathway from psychology to cellular energetics.
Yoga and slow-breathing practices improve HRV and stress/oxidative markers in trials; direct mitochondrial readouts are limited but the stress-reduction pathway is plausible.
The circadian clock directly schedules mitochondrial biogenesis, dynamics and mitophagy; keeping regular light, meal and sleep timing supports that rhythm. Shift work disrupts it.
Morning outdoor light anchors the circadian clock and improves sleep and mood in trials; mitochondrial benefit is indirect, via better circadian and metabolic regulation.
Night-shift and irregular light-dark exposure desynchronize mitochondrial and metabolic rhythms and are linked in cohorts to metabolic and cardiovascular disease.
Red/NIR light is absorbed by Complex IV (cytochrome c oxidase), transiently boosting ATP output. Small human trials show muscle-recovery and some cognitive effects; protocols vary widely.
Finnish cohorts strongly link frequent sauna to lower cardiovascular and all-cause mortality; heat stress induces heat-shock proteins and may drive mitochondrial biogenesis (heat as exercise-mimetic).
Repeated hot baths improve vascular function and glycemic control in small trials, with heat-shock-protein pathways implicated in mitochondrial adaptation.
Cold activates brown/beige fat and PGC-1α-driven mitochondrial biogenesis in humans; benefits for metabolism are real but modest, and cold right after strength training can blunt gains.
Popular for recovery, but controlled evidence for lasting mitochondrial or performance benefit is weak and inconsistent compared with simple cold-water immersion.
Robust cohort evidence ties social connection to longevity; the mitochondrial link is indirect — via lower chronic stress, inflammation and better health behaviours.
Chronic loneliness raises inflammatory and stress signalling and predicts worse health outcomes in large cohorts — a plausible upstream driver of mitochondrial stress.
Mentally demanding activity engages neuronal energy metabolism and supports cognitive reserve, but direct evidence that 'brain training' improves mitochondrial function is minimal. Included for completeness and honesty.
Fine-particulate exposure is associated in human biomarker studies with mitochondrial DNA damage, altered mtDNA copy number and oxidative stress. Reducing exposure matters.
Smoking directly damages the respiratory chain and mitochondrial DNA and is one of the most robustly harmful mitochondrial exposures known. Quitting is the highest-impact fix here.
Many environmental toxicants (arsenic, lead, certain pesticides like rotenone/paraquat) inhibit respiratory complexes and are linked to mitochondrial disease and Parkinson's risk.
Access to green space is linked in cohorts to lower stress and better cardiometabolic health; the mitochondrial benefit is indirect, through stress reduction and more physical activity.
Your VO₂max is essentially a whole-body readout of mitochondrial oxidative capacity — and one of the strongest predictors of all-cause mortality in large cohorts. Raising it is the headline goal of most training.
Regular nut intake is tied in large cohorts and trials to lower cardiometabolic risk and mortality; their polyphenols and unsaturated fats support membranes and lower oxidative stress.
Gut bacteria ferment fibre into short-chain fatty acids like butyrate — the primary fuel for colon-cell mitochondria — and higher intake improves metabolic and inflammatory markers.
A Blue-Zones staple: swapping some animal protein for legumes is associated with better metabolic profiles and longevity, easing the metabolic load on mitochondria.
Persistent calorie surplus floods mitochondria with more fuel than they can cleanly burn, driving reactive-oxygen production and insulin resistance — arguably the most common mitochondrial stressor of all.
A carotenoid that sits inside membranes as an unusually potent antioxidant; small human trials suggest benefits for muscle endurance and skin, with mitochondrial protection as the proposed mechanism.
An essential cofactor for glutathione peroxidase, a key mitochondrial antioxidant enzyme; correcting deficiency helps, but excess selenium is toxic — dose matters.
A fat-soluble membrane antioxidant in theory, but large trials are mostly null and high doses have shown harm signals. Underwhelming as a supplement despite the tidy mechanism.
At low doses it can shuttle electrons to Complex IV, potentially rescuing stalled respiration; small human cognition studies are intriguing, but it interacts dangerously with serotonergic drugs.
These amino acids raise nitric oxide, a signal for mitochondrial biogenesis and better blood flow; ergogenic trials are mixed but the vascular/mito rationale is sound.
A sugar that feeds directly into ATP regeneration; small trials in heart failure and fatigue syndromes are suggestive but far from conclusive.
A polyphenol studied for mitochondrial biogenesis and (with dasatinib) as a senolytic; human mitochondrial-outcome data are thin and effects modest.
A prescription diabetes drug that activates PPARγ to promote mitochondrial biogenesis and insulin sensitivity — but carries weight-gain, fluid-retention and fracture risks.
Sleep *regularity* — going to bed and waking at steady times — predicts metabolic health and mortality independent of duration, keeping the clock that schedules mitochondrial housekeeping on track.
Sensible sun exposure drives natural vitamin D synthesis, linked to muscle mitochondrial function — balanced against real skin-cancer risk, so moderation and skin type matter.
Evening light — especially blue — suppresses melatonin and desynchronises the circadian clock; dimming screens and lights at night helps protect the rhythms that govern mitochondrial repair.
A strong sense of purpose predicts lower mortality and inflammation in large cohorts; the mitochondrial link is indirect, via reduced chronic-stress signalling.
A fast-moving concern: micro- and nanoplastics and plasticizers (like phthalates) show mitochondrial and endocrine-disrupting effects in lab and early biomarker studies. Reducing exposure is prudent.
Learning new, demanding skills engages neuronal energy metabolism and builds cognitive reserve; direct evidence that it improves mitochondrial function is minimal — included for honesty.
Alternating heat and cold is popular for recovery and circulation; controlled evidence for a lasting mitochondrial benefit beyond the sum of sauna and cold is limited and mixed.
Nothing matches — loosen a filter.
This is a synthesis for orientation, not medical advice. Evidence for many mitochondrial-specific effects is indirect; ratings reflect the best available human data plus mechanism. Found a strong study I'm missing? tell me.